Contingency Management for Stimulant Use Disorder – Broadway Treatment Center

Medically reviewed by the Broadway Treatment Center clinical review team. Last updated August 16, 2026.

Contingency Management in Orange County

Looking for a Meth or Cocaine Program That Actually Uses Evidence-Based Care?

Broadway Treatment Center helps you find outpatient programs in Orange County and across California that use contingency management and other evidence-based approaches for stimulant use disorder. We verify your benefits and coordinate admission before you commit to anything.

Call Now: (714) 400-2048

If this is an emergency, call 911. Stimulant use can cause chest pain, seizures, dangerously high body temperature, stroke, and acute psychosis, all of which are medical emergencies. If you or someone you love is having thoughts of suicide or is in emotional crisis, call or text 988 to reach the Suicide & Crisis Lifeline, available 24 hours a day. For confidential, no-pressure help finding a treatment program, call Broadway Treatment Center at (714) 400-2048.

Contingency management is a behavioral treatment that gives a person a small, tangible reward each time an objective test confirms they have met a specific recovery goal, most often a urine drug test that is negative for stimulants. It is currently the single most effective treatment researchers have identified for methamphetamine and cocaine use disorder, and it is the only approach with strong evidence behind it in a category where no medication has ever been approved by the FDA. If you have been told that “nothing works” for meth or cocaine, this is the part of the picture that was probably left out.

This page explains what contingency management is, the behavioral science it rests on, how a real protocol is structured week by week, how California became the first state in the country to cover it as a Medicaid benefit, what it cannot do, and how to find a program that offers it. It is written for the person searching at 2 a.m. after another lost week, and for the parent or partner who has already tried everything they know how to try.

An important disclosure first: Broadway Treatment Center is a treatment placement and referral service, not a treatment facility. We do not own, operate, or staff a clinic, and we do not deliver contingency management ourselves. What we do is help you understand your options, verify your insurance benefits, and connect you with licensed providers in our network who deliver this care. Everything below is educational information, not medical advice.

What Is Contingency Management?

Contingency management, usually shortened to CM, is a structured behavioral intervention in which a person receives a tangible reinforcer, such as a gift card, voucher, or prize draw, contingent on objective evidence that they performed a specific target behavior. The word “contingent” is doing the real work in that sentence. The reward is never given for showing up in a good mood or for saying the right things in group. It is given only when something measurable and verifiable has happened, and it is withheld when it has not.

In most stimulant protocols, the target behavior is a urine drug test that comes back negative for methamphetamine, amphetamine, or cocaine. Other protocols reinforce treatment attendance, medication adherence, or completion of specific recovery activities. What all of them share is that the behavior is defined in advance, verified objectively, and reinforced immediately.

That immediacy matters more than most people expect. Substance use delivers a reward within seconds. Recovery, by contrast, delivers its rewards over months and years: a repaired relationship, a job that lasts, a body that recovers. Contingency management is an attempt to close that gap by placing a small, immediate, reliable reward on the recovery side of the ledger, at the exact moment the behavior occurs.

The behavioral principle underneath it

CM is built on operant conditioning, specifically positive reinforcement: a behavior that is followed by a reward becomes more likely to recur. This is not a novel or fringe idea. It is one of the most thoroughly replicated findings in the behavioral sciences, and it has been applied to substance use disorders in controlled research for roughly three decades.

Chronic stimulant use progressively narrows what the brain’s reward circuitry responds to. Methamphetamine and cocaine both act on dopamine signaling with a force and speed that ordinary rewards cannot match, and over time, activities that used to feel meaningful register as flat. Clinicians sometimes describe this as anhedonia, and it is one of the reasons early stimulant recovery is so difficult: the person is asked to give up the one thing that reliably produces a signal, in exchange for a period during which very little produces any signal at all. CM does not fix that neurobiology, but it does insert a concrete, repeated, immediate reinforcer into precisely the window where natural reinforcement is weakest.

Why Stimulant Use Disorder Is the Strongest Case for Contingency Management

Contingency management has evidence supporting its use across several substance use disorders, including opioid, cannabis, alcohol, and tobacco use disorders. But its strongest and most consistent evidence is for stimulant use disorder, and there is a specific structural reason for that.

For opioid use disorder, there are approved medications with substantial evidence behind them: buprenorphine, methadone, and extended-release naltrexone. For alcohol use disorder, there are naltrexone, acamprosate, and disulfiram. For stimulant use disorder, involving methamphetamine, cocaine, or prescription stimulants such as amphetamine salts and methylphenidate, there is no FDA-approved medication at all. Various agents and combinations have been studied and some show enough signal that clinicians may consider off-label use, but none has been approved for this indication.

That absence leaves behavioral treatment carrying the full clinical load. And within behavioral treatment, the comparative research is unusually clear. Reviews of contingency management for stimulant use disorder describe it as among the most effective available treatments, roughly twice as effective as alternatives such as cognitive behavioral therapy, standard counseling, and motivational interviewing when measured against outcomes like confirmed abstinence during treatment. Studies comparing CM with other psychosocial interventions have found higher abstinence rates across the course of treatment, higher retention in treatment, and higher abstinence self-efficacy.

Two honest caveats belong next to that finding. First, “twice as effective” is a comparison against other psychosocial treatments, not a cure rate, and not a promise about any individual. Second, the strongest effects are observed during the period when incentives are actively being delivered, and effects attenuate after a program ends. This is one of the central criticisms of CM and it is addressed directly further down this page.

The clinical picture CM is being asked to address

Stimulant withdrawal differs fundamentally from alcohol or benzodiazepine withdrawal, and understanding that difference explains why the treatment approach differs too.

  • Alcohol and benzodiazepine withdrawal are pharmacologically dangerous. They carry genuine seizure and delirium risk, they are assessed with structured scales such as the CIWA-Ar, and they are managed with medication, typically benzodiazepines on a symptom-triggered or tapering schedule. Medical detox is not optional for people with significant physiological dependence.
  • Opioid withdrawal is intensely uncomfortable but generally not directly life-threatening for otherwise stable adults. It is scored with the COWS, and it is managed with buprenorphine or methadone initiation plus comfort medications such as clonidine, ondansetron, and loperamide.
  • Stimulant withdrawal is primarily psychiatric rather than pharmacologically driven. The acute phase, often called the crash, typically brings profound fatigue, hypersomnia, increased appetite, agitation, and vivid dysphoria over the first several days. What follows is frequently a longer stretch of depressed mood, blunted pleasure, poor concentration, and intense craving that can persist for weeks. The serious risks in this phase are suicidal ideation and, in some cases, stimulant-induced psychosis with paranoia and hallucinations, which can outlast the drug itself.

Because there is no medication that reliably shortens or blunts this course, and because the highest-risk period is one of low motivation and flattened reward response, an intervention that supplies external, immediate, reliable reinforcement is well matched to the problem. You can read more about the acute course in our guides to the methamphetamine withdrawal timeline and cocaine withdrawal symptoms, and about the psychiatric complications in our overview of stimulant-induced psychosis.

How a Contingency Management Protocol Actually Works

A well-designed CM protocol is far more specific than “rewarding people for staying clean.” Decades of research have identified the design parameters that determine whether it works, and programs that get those parameters wrong tend to get weak results. Here is what a serious protocol specifies.

1. A single, objectively verifiable target behavior

The behavior must be measurable without clinical judgment. For stimulant protocols this is nearly always a point-of-care urine drug test that is negative for the target stimulant. Self-report is not used as the basis for reinforcement, not because participants are assumed to be dishonest, but because a reinforcement schedule loses its power the moment the criterion becomes negotiable.

2. Frequent testing

Testing typically happens two to three times per week rather than weekly or monthly. Frequency serves two purposes: it matches the detection window for stimulants, which clear relatively quickly, and it keeps the interval between behavior and reward short enough for the reinforcement to register. Programs that test infrequently are, in behavioral terms, delivering a delayed reward, which is exactly the deficit CM is meant to correct.

3. Immediate delivery of the reinforcer

The incentive is provided at the visit, on the spot, not mailed later or accrued toward a distant payout. Delay erodes effect.

4. An escalating schedule with a reset

This is the design feature people find most counterintuitive, and it is central. The value of the reinforcer increases with each consecutive success, and it resets to the starting level after a positive test or a missed visit. In a voucher-based model, a first negative test might earn a small fixed amount, the next slightly more, the next more again. In a prize-based model, sometimes called the fishbowl method, a participant earns draws from a container holding slips of varying value, and the number of draws increases with consecutive successes.

The escalation rewards streaks, which is what recovery from stimulant use actually requires. The reset is not a punishment; nothing is taken away that was already earned. It simply means the ladder starts again from the bottom, which preserves the value of a streak and gives the person a concrete reason to protect one.

5. Adequate magnitude

Incentive magnitude correlates with effect size in the research literature. Protocols with reinforcers too small to be meaningful tend to underperform. In practice, real-world programs must balance this against regulatory limits on what a publicly funded program may provide, which is one reason the design of California’s benefit, described below, was a significant policy exercise and not just a clinical one.

6. A defined duration and a plan for what follows

CM protocols run for a set number of weeks and then end. A well-run program treats the transition off incentives as a clinical event to be planned for, not an administrative end date. The programs most likely to produce durable results wrap CM inside a broader treatment plan and step the person into ongoing recovery support as the incentive schedule winds down.

Prize-Based vs Voucher-Based Contingency Management

The two dominant CM structures both work through the same mechanism but distribute reinforcement differently. Neither is universally superior; programs choose based on budget, regulatory constraints, and population.

FeatureVoucher-Based CMPrize-Based CM (Fishbowl)
How the reward is deliveredA fixed, known value is earned for each verified negative testVerified negative test earns draws from a container of slips with varying values
CertaintyGuaranteed amount; the participant knows exactly what a negative test is worthVariable; many draws are low value or non-monetary, a few are larger
EscalationValue per test rises with each consecutive negative resultNumber of draws rises with each consecutive negative result
Reset after a positive testValue returns to the starting amountDraw count returns to the starting number
Cost profileHigher and more predictable total expenditure per participantLower average expenditure because not every draw carries high value
Behavioral characterPredictable reinforcement; transparent and easy to explainIntermittent reinforcement; some clinicians raise concerns about its resemblance to gambling for certain participants
Common settingResearch trials and well-funded programsPublicly funded and community programs where budgets are constrained

One clinical note worth raising: for a person with a co-occurring gambling problem, the variable-reward structure of the fishbowl model is a reasonable thing to discuss with the treating clinician. This is the kind of individual factor a clinical assessment is meant to surface. Our overview of gambling addiction and substance use disorder covers how often those conditions travel together.

California’s Recovery Incentives Program: The First Medicaid Contingency Management Benefit in the Country

For most of its history, contingency management existed largely inside research trials, because paying people in connection with treatment raised complicated questions under federal healthcare regulations. California changed that. Through the CalAIM Section 1115 Demonstration, California became the first state in the nation to receive federal approval to cover contingency management as a Medicaid benefit, delivered through the Recovery Incentives Program administered by the California Department of Health Care Services.

Here is what the state has published about how the benefit is structured.

  • Who it is for: eligible Medi-Cal beneficiaries with stimulant use disorder, served through participating Drug Medi-Cal Organized Delivery System (DMC-ODS) counties.
  • Structure: a 24-week outpatient program. Weeks 1 through 12 function as the escalation, reset, and recovery period. Weeks 13 through 24 function as the stabilization period.
  • What is reinforced: urine drug tests that are negative for stimulants.
  • Incentives: a small gift card for each negative test, with participants able to earn up to $599 per participant per year in incentives.
  • What follows: six or more months of additional recovery support services after the 24-week CM period ends.
  • Rollout: DHCS ran a pilot from March 2023 through March 2024. DMC-ODS counties may elect to opt in and offer CM services at any time through the CalAIM 1115 demonstration period, which runs through December 31, 2026.

Two details in that list deserve emphasis. The first is the deliberate two-phase design: the program does not simply run one schedule for 24 weeks, it escalates during the first half and stabilizes during the second, which reflects the research on how reinforcement schedules should change as a behavior becomes established. The second is the mandated tail of recovery support services. The state built the “what happens when incentives stop” problem into the benefit rather than leaving it to chance.

An important limitation on what we can tell you: county participation is opt-in and changes over time, and we will not tell you that any particular Orange County program offers this benefit without you confirming it. Whether a given DMC-ODS county or provider is currently delivering the Recovery Incentives Program has to be verified directly, with the county behavioral health department, with DHCS, or through the provider itself. If you would like help working through that, call us at (714) 400-2048 and we will help you check. Broader implementation and training materials are maintained by the UCLA Integrated Substance Abuse Programs, which supports the program’s rollout.

It is also worth being clear that the Recovery Incentives Program is a Medi-Cal benefit. If you have commercial insurance, an employer plan, or a PPO, this specific program is not your route. Some private and commercial programs do incorporate contingency management or CM-informed elements into their outpatient care, but availability varies widely by provider. That is exactly the kind of question our placement team can help you ask before you commit to a program. You can start with our insurance verification page.

Contingency Management Works Best Inside a Complete Treatment Plan

Whether CM fits depends on the substance involved, the severity of use, any co-occurring psychiatric conditions, your housing and work situation, and your insurance. A clinical assessment can help determine the safest and most appropriate next step, and a benefits check tells you which programs are realistically available to you.

What Contingency Management Is Not

Setting accurate expectations is part of responsible information about any treatment. CM is genuinely well supported, and it is also frequently oversold. Here is the other side.

It is not a standalone treatment

CM reinforces a behavior. It does not teach coping skills, treat underlying depression or PTSD, repair a damaged relationship, resolve housing instability, or address the reasons a person started using. In both research and practice, CM is layered onto a treatment program, commonly one that includes cognitive behavioral therapy, community reinforcement approaches, case management, and psychiatric care where indicated. A program that offers gift cards and nothing else is not delivering contingency management as the evidence describes it.

Its effects weaken after incentives stop

This is the most substantive criticism of CM and it is a fair one. Abstinence rates are strongest during the active incentive period and tend to decline after a protocol ends, though many studies find some advantage persists. This is precisely why California’s benefit attaches six or more months of recovery support services to the back end of the 24-week program, and why any good program should be planning the post-CM period from the start. If you are evaluating a program, ask what happens in month seven. The quality of that answer tells you a great deal.

It is not a substitute for medical care when medical care is needed

If someone is using stimulants alongside alcohol, benzodiazepines, or opioids, the withdrawal risk profile changes completely and medical supervision may be necessary before any outpatient behavioral program is appropriate. Alcohol and benzodiazepine withdrawal can be life-threatening. Combined stimulant and opioid use, increasingly common with fentanyl in the supply, carries serious overdose risk. Our guide to polysubstance use disorder covers why mixed use changes the clinical calculus, and levels of care in addiction treatment explains how programs decide what setting a person needs.

It is not “paying people to be sober” in any simple sense

This objection comes up constantly and deserves a direct answer. The incentives in real programs are modest, capped, and structured. Under California’s benefit, the annual ceiling is $599 per participant. Nobody is getting rich, and nobody stays in a demanding, thrice-weekly, urine-tested, 24-week outpatient protocol for a gift card. What the incentive does is provide a reason to come back this week, during the specific window when the internal reasons have gone quiet. The clinical work is what happens once the person is in the room.

Where Contingency Management Fits in the Levels of Care

Contingency management is an outpatient intervention. It requires a person who can travel to a testing site two to three times a week, which makes it structurally incompatible with residential care during the residential stay itself, though some residential programs use CM-informed reinforcement internally and many people enter a CM protocol as they step down.

Outpatient / IOP with CMResidential Treatment
Best suited forStable housing, some external structure, ability to attend visits 2 to 3 times weeklyUnsafe or using home environment, severe use, failed outpatient attempts, significant psychiatric instability
StructureScheduled visits, frequent point-of-care testing, therapy groups, case management24-hour supervised setting, full daily clinical programming
Contingency managementCore deliverable; the schedule depends on the person living in the communityNot typically delivered as a formal CM protocol during the stay; often begins at step-down
Work and familyOften possible to maintain employment and stay at homeRequires stepping away from work and household responsibilities
Handles medical withdrawal riskNo; alcohol or benzodiazepine dependence needs medical detox firstYes, or coordinates directly with a detox level of care
Typical duration24 weeks under California’s benefit; varies elsewhereCommonly 30 to 90 days, based on clinical assessment

If you are unsure which setting applies, our comparison of PHP vs IOP walks through the intensity tiers within outpatient care, and substance abuse treatment gives the broader overview of the programs our network partners offer.

Combining CM With Other Evidence-Based Treatment

The strongest programs treat CM as one component in a stack. Several combinations have meaningful support behind them.

  • CM plus cognitive behavioral therapy. CM handles the immediate reinforcement problem while CBT builds the skills for identifying triggers, restructuring the thinking that precedes use, and planning for high-risk situations. The two address different failure points.
  • CM plus the community reinforcement approach. CRA works to rebuild a life in which non-drug activities, relationships, and employment become genuinely reinforcing, which directly targets the durability problem CM alone has.
  • CM plus medication for a co-occurring opioid use disorder. Stimulant and opioid use together is now common. Where opioid use disorder is present, buprenorphine or methadone remains the standard of care, and CM can be layered to target the stimulant use that medication does not address. See our page on medication-assisted treatment.
  • CM plus psychiatric treatment for co-occurring conditions. Depression, PTSD, ADHD, anxiety disorders, and stimulant-induced psychiatric symptoms all complicate stimulant recovery, and they need their own treatment. Our dual diagnosis page explains how integrated treatment is structured.
  • CM plus craving-focused skills work. Stimulant craving is powerful and cue-driven. Practical craving management gives the person something to do in the moment between the cue and the use. See how to manage cravings in recovery.

Stimulant Use in Orange County and Southern California

Broadway Treatment Center works with people across Orange County, and the local pattern shapes what placement looks like. Methamphetamine has been an established presence in Southern California for decades, and the current supply is high-purity and inexpensive. Cocaine use tends to cluster differently, appearing more often in professional and nightlife contexts along the coast. Prescription stimulant misuse shows up in a third pattern again, particularly among students and working professionals managing performance demands.

The complicating factor across all three is contamination. Fentanyl has been found in counterfeit pills and in non-opioid drug supplies, which means a person who believes they are using only a stimulant may be exposed to an opioid, without any tolerance to it. This is the single most important safety message on this page for anyone currently using: carry naloxone, and do not use alone. Naloxone reverses opioid overdose and does nothing harmful if opioids are not involved, which makes carrying it a reasonable precaution for a stimulant user in this supply environment. Our guide on how to use naloxone covers administration.

We coordinate placement with licensed providers serving communities across the county, including Huntington Beach, Newport Beach, Costa Mesa, Irvine, Santa Ana, Anaheim, Fountain Valley, Garden Grove, Westminster, and Buena Park. Practical geography matters more than usual with contingency management: a protocol that requires attendance two to three times a week only works if the site is genuinely reachable. When we help someone evaluate options, commute time is a clinical variable, not a convenience.

Insurance and Access

Access to contingency management depends heavily on coverage type, and it is worth being direct about the landscape.

  • Medi-Cal. The Recovery Incentives Program is the formal route, available through participating DMC-ODS counties. Participation is opt-in and must be confirmed for your county and provider.
  • Commercial and employer plans. Outpatient substance use treatment is generally a covered benefit category, but formal CM protocols are less commonly a defined covered service. Some programs deliver CM or CM-informed care regardless. Specific benefits, authorization requirements, and network status have to be verified plan by plan.
  • What we can and cannot tell you. We verify benefits before any commitment, and we will tell you what we find. We do not guarantee coverage, in-network status, out-of-pocket amounts, or that a particular program has an opening. Anyone who guarantees those things before running a verification is not being straight with you.

If you want the benefits question answered before you make any decisions, call (714) 400-2048 or start with insurance verification. There is no obligation attached to finding out.

What Happens When the Program Ends

A 24-week protocol ends. Planning for that ending is the difference between a program that produced six good months and a program that produced a durable change.

Well-designed transitions generally include several elements: continued outpatient therapy at a reduced intensity, an explicit relapse prevention plan built while the person is still stable rather than after a crisis, connection to peer or mutual-aid support, ongoing psychiatric care where a co-occurring condition is being treated, and attention to the practical scaffolding of housing and employment. The underlying goal is to replace the external reinforcement of the incentive schedule with internal and social reinforcement that does not have an end date, which is precisely what the community reinforcement approach is designed to do.

Building that plan deliberately is worth real effort. Our guide to relapse prevention planning covers how to construct one, and managing cravings in recovery addresses the day-to-day skills that carry the load once the structure of a program is gone.

Contingency Management Is One Stage, Not the Whole Recovery Plan

After a structured incentive program comes ongoing outpatient therapy, relapse prevention work, and continued support for any co-occurring condition. Understanding the full continuum makes it much easier to choose a program that will still be useful in month seven.

View Levels of Care in Addiction Treatment

How to Get Help Today

  1. Call (714) 400-2048. Our placement team is available 24 hours a day. The call is confidential, and nothing is committed to by making it.
  2. Describe what is actually happening. Which substances, how much, how long, whether alcohol or benzodiazepines or opioids are also involved, any psychiatric symptoms, and any prior treatment. Accuracy here directly determines whether the placement is appropriate.
  3. Let us verify your benefits. We check coverage before any commitment and tell you what the verification actually returns, including when the answer is not what you hoped.
  4. Get matched to a clinical assessment. A licensed provider in our network determines the appropriate level of care. If medical withdrawal management is needed first, that comes before any outpatient behavioral program.
  5. Ask directly whether contingency management is offered. If it matters to you, ask the program, and ask what happens after the protocol ends. We will help you frame the question.
  6. Coordinate admission. We handle the logistics of connecting you with the provider. Admission always depends on clinical assessment, availability, and any required authorization.

In an emergency, call 911. Chest pain, seizure, extreme agitation, dangerously high body temperature, or signs of stroke during stimulant use require emergency medical care immediately. If you are having thoughts of suicide, call or text 988 to reach the Suicide & Crisis Lifeline, available 24 hours a day, seven days a week. Suicidal thinking is a recognized feature of stimulant withdrawal and it is a reason to get help now, not to wait it out. For confidential help finding treatment, call Broadway Treatment Center at (714) 400-2048.

Frequently Asked Questions About Contingency Management

What is contingency management in addiction treatment?

Contingency management is a behavioral treatment in which a person receives a small, tangible reward, such as a gift card or prize draw, each time an objective test confirms a specific target behavior, most often a urine drug test negative for stimulants. It applies the principle of positive reinforcement to recovery behaviors. It is delivered as part of a broader outpatient treatment program, not on its own.

Does contingency management actually work for meth addiction?

Research reviews describe contingency management as among the most effective available treatments for stimulant use disorder, including methamphetamine, and roughly twice as effective as comparison psychosocial treatments such as CBT or counseling on measures like confirmed abstinence and treatment retention. That is a statement about average results across studies, not a prediction for any individual, and effects are strongest while incentives are actively being delivered.

Is there a medication for methamphetamine or cocaine addiction?

There is no FDA-approved medication for stimulant use disorder. Several agents and combinations have been studied, and some clinicians consider off-label use in specific situations based on the available evidence. Any medication decision is one for a treating physician who knows the full clinical picture, and it does not replace behavioral treatment.

How much money do you get in contingency management?

Amounts are modest and capped. Under California’s Recovery Incentives Program, participants receive a small gift card for each stimulant-negative urine test and can earn up to $599 per participant per year. Values escalate with consecutive negative tests and reset to the starting level after a positive test or missed visit. Programs outside that benefit vary.

How long does a contingency management program last?

California’s Recovery Incentives Program runs 24 weeks, with weeks 1 through 12 serving as the escalation, reset, and recovery period and weeks 13 through 24 as the stabilization period, followed by six or more months of additional recovery support services. Protocols outside that program vary in length, and duration should be matched to the person’s clinical needs.

What happens if I test positive during the program?

In a standard escalating protocol, a positive test resets the incentive value or number of draws back to the starting level. Nothing already earned is taken away. A positive test is not typically grounds for discharge; it is clinical information that the treatment plan may need adjusting. Programs differ in their specific policies, so ask directly.

Is contingency management just paying people not to use drugs?

That framing misses how it functions. The incentives are small and capped, and no one completes a demanding 24-week protocol with thrice-weekly testing for a gift card. The reinforcer serves to bring the person back during the early weeks when internal motivation and natural reward response are at their lowest. The clinical work happens once they are in the room.

Does insurance cover contingency management?

For eligible Medi-Cal beneficiaries in participating DMC-ODS counties, contingency management is available through the Recovery Incentives Program. Coverage under commercial and employer plans varies considerably and formal CM protocols are less commonly a defined covered service, though outpatient treatment generally is. Benefits should be verified before any commitment. Call (714) 400-2048 and we will help you check.

Is contingency management available in Orange County?

County participation in California’s Recovery Incentives Program is opt-in and can change over time, so availability in any specific county or at any specific provider has to be confirmed directly rather than assumed. We can help you check current availability and identify programs in our network. Call (714) 400-2048.

Do I need detox before starting contingency management?

Stimulant withdrawal on its own does not usually require medically supervised detox, because it is primarily psychiatric rather than pharmacologically dangerous. However, if alcohol, benzodiazepines, or opioids are also involved, medical withdrawal management may be necessary first, since alcohol and benzodiazepine withdrawal can be life-threatening. A clinical assessment determines this.

How often will I be drug tested?

Contingency management protocols typically involve point-of-care urine testing two to three times per week. That frequency matches the detection window for stimulants and keeps the interval between the behavior and the reinforcement short, which is essential to how the intervention works.

What is the difference between prize-based and voucher-based CM?

Voucher-based CM delivers a known, fixed value for each verified negative test, escalating with consecutive successes. Prize-based CM, sometimes called the fishbowl method, awards draws from a container of slips with varying values, with the number of draws escalating. Both reset after a positive test. Prize-based programs generally cost less to run; voucher-based programs are more predictable for the participant.

Does contingency management work for opioid or alcohol use disorder?

Contingency management has research support across several substance use disorders, including opioid, cannabis, alcohol, and tobacco use disorders. Its strongest evidence is for stimulant use disorder, largely because effective approved medications exist for opioid and alcohol use disorder and do not exist for stimulants. For opioid use disorder, medication remains the standard of care, and CM may be added.

What happens after the 24 weeks end?

California’s benefit attaches six or more months of additional recovery support services after the contingency management period. More broadly, a good transition includes continued outpatient therapy at reduced intensity, a relapse prevention plan built before it is needed, peer or mutual-aid connection, and ongoing psychiatric care where relevant. Ask any program you are evaluating what their post-program plan looks like.

Can I keep working while in a contingency management program?

Often yes, because CM is delivered in outpatient settings. The practical constraint is attending testing visits two to three times a week, so scheduling and travel time are real factors. For some people an intensive outpatient schedule alongside work is manageable; for others a period of residential care comes first. A clinical assessment sorts this out.

Will contingency management help if I also have depression or PTSD?

Contingency management targets substance use behavior; it does not treat a psychiatric condition. Co-occurring depression, PTSD, ADHD, or anxiety disorders need their own treatment, delivered in an integrated way alongside substance use care. Programs that treat both together are generally the appropriate fit, and that should be part of the placement conversation from the start.

Is stimulant withdrawal dangerous?

Stimulant withdrawal is not pharmacologically dangerous in the way alcohol or benzodiazepine withdrawal is, but it carries real psychiatric risk. Severe depression, suicidal thinking, and in some cases stimulant-induced psychosis with paranoia or hallucinations can occur. Those are reasons to seek care, not to wait. If someone is having thoughts of suicide, call or text 988. In an emergency, call 911.

My partner is using meth and refuses treatment. Does any of this help?

Contingency management requires the person to participate, so it is not a route around refusal. What often does help is a structured conversation, sometimes with professional guidance, and being ready with a concrete option at the moment willingness appears. Our pages on how to talk to a loved one about rehab and how to help an addicted loved one cover this. You can also call us at (714) 400-2048 to think it through.

Why did California start covering contingency management?

Contingency management had strong research support but limited real-world availability, partly because providing incentives in connection with healthcare raised regulatory questions. Through the CalAIM Section 1115 Demonstration, California became the first state to receive federal approval to cover it as a Medicaid benefit, creating the Recovery Incentives Program for beneficiaries with stimulant use disorder.

How do I find a program that offers contingency management?

Start by confirming your coverage type, since Medi-Cal and commercial plans lead to different routes. Then ask programs directly whether they deliver contingency management, how the protocol is structured, and what follows it. You can search licensed providers through SAMHSA’s treatment locator, or call our placement team at (714) 400-2048 and we will help you narrow the options and verify benefits.

Trusted Sources and Authority References

Editorial Disclaimer

This article was written and reviewed by the Broadway Treatment Center clinical review team for accuracy against published federal and California state sources as of August 16, 2026. Broadway Treatment Center is a treatment placement and referral service, not a treatment facility. We do not own, operate, or staff a clinic and we do not deliver contingency management, detoxification, or any other clinical service directly. We help people understand their options, verify insurance benefits, and connect with licensed, verified providers in our network.

This content is for general educational purposes and is not medical advice, a diagnosis, or a treatment recommendation for any individual. It does not establish a clinical relationship. Program availability, county participation in California’s Recovery Incentives Program, protocol details, and insurance coverage all change over time and vary by provider and plan; verify current details directly. Admission to any program depends on clinical assessment, bed or slot availability, and any required authorization, and cannot be guaranteed in advance. Insurance coverage, in-network status, and out-of-pocket responsibility are verified before any commitment and are never guaranteed ahead of verification. Always consult a qualified healthcare professional about your specific situation. If this is a medical emergency, call 911. If you are in emotional crisis or having thoughts of suicide, call or text 988.